succinic acid monoethyl ester prevents oxidative stress in streptozotocin-nicotinamide-induced type2 diabetic rats

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 17, Issue 2, 2006, Pages 115-132

  Saravanan, Ramalingam ^a   Pari, Leelavinothan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

antioxidants; catalase; diabetes mellitus; lipid peroxidation; metformin; superoxide dismutase

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; NICOTINAMIDE; SUCCINIC ACID METHYL ESTER; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL MODEL; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; INSULIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; RAT; REVIEW; STREPTOZOCIN DIABETES;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD GLUCOSE; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; INSULIN; LIPID PEROXIDATION; MALE; NIACINAMIDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUCCINATES; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN E;

EID: 33745910848     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.2006.17.2.115     Document Type: Article

References (55)

1. ndEdition. Oxford, UK: Clarendon Press, 1989.
2. Signorini, AM, Fondelli, C, Renzoni, E, Puccetti, C, Gragnoli, G, Giorgi, G. Antioxidant effect of gliclazide, glibenclamide and metformin in patients with type 2 diabetes mellitus. Curr Ther Res 2002; 63: 411–420.
3. Halliwell, B, Gutteridge, JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990; 186: 81–85.
4. Halliwell, B, Gutteridge, JM. Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet 1994; 344: 1396–1397.
5. Simmons, KJ. Defense against free radicals has therapeutic implications. J Am Med Assoc 1984; 251: 2187–2192.
6. Wohaieb, SA, Godin, DV. Alterations in free radical tissue defense mechanism in STZ induced diabetes in rat, effects of insulin treatment. Diabetes 1987; 36: 1014–18.
7. Picton, SF, Flatt, PR, Mcclenghan, NH. Differntial acute and long term actions of succinic acid monomethyl ester exposure on insulin secreting BRAIN-BD 11 cells. Int J Exp Diabetes Res 2001; 2: 19–27.
8. Akkan, AG, Malaisse, WJ. Protective effect of succinic acid monomethl ester aginst streptozotocin induced diabete mellitus. Med Sci Res 1993; 214: 467.
9. To, K, Tsubamoto, Y, Terauchi, Y. Role of NADH shuttle system in glucose induced activation of mitochondrial metabolism and insulin secretion. Science 1999; 283: 981–985.
10. Ishihara, H, Wang, H, Drewes, LR, Wollheim, CB. Over expression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells. J Clin Invest 1999; 104: 1621–1629.
11. Ainscow, EK, Zhao, C, Rutter, GA. Acute over expression of lactate dehydrogenase-A perturbs beta-cell mitochondrial metabolism and insulin secretion. Diabetes 2000; 49: 1149–1155.
12. Alarcon, C, Wicksteed, B. Succinate is a preferential metabolic stimulus-coupling signal for glucose-induced proinsulin biosynthesis translation. Diabetes 2002; 51: 2496.
13. Zawalich, WS, Zawalich, KC. Biochemical mechanisms involved in monomethyl succinate-induced insulin secretion. Endocrinol 1992; 131: 649–654.
14. Ladriere, L, Louchami, K, Vinamber, C, Kadiata, MM, Jijakli, H, Villanueva-Penacarrillo, ML, et al. Insulinotropic action of the monoethyl ester of succinic acid. Gen Pharmacol 1998; 31: 377–383.
15. Juan, A, Martinez, G, Maria, L, Penacarrillo, V, Valverde, I, Bjorkling, F, et al. Potentiation of the insulinotropic and hypoglycemic action of gliquidone by succinic acid esters. Eur J Pharmacol 1998; 325: 65–68.
16. Saakian, MR, Kondrashova, MN, Vysochina, IV. The correction of disorders of the internal body environment in animals and man by the addition of succinic acid to food. Izv Akad Nauk Ser Biol 1994; 4: 596–604. [article in Russian]
17. Gorbenko, NI, Poltork, VV, Gladkikh, AI, Ivanova, OV. Effect of phensuccinal on pancreatic beta cell in rats with neonatally induced streptozotocin diabetes mellitus. Bull Exp Biol Med 2001; 132: 556–559.
18. Gonchar, O, Klyuchko, E, Seredenko, M, Oliynik, S. Correction of prooxidant and antioxidant homeostasis of organism under hypoxia of different geness by Yackton, a new pharmacological preparation. Acta Physiol Pharmacol Bulg 2003; 27:53–58.
19. Neil, MJ. Metformin. In: O’Neil, MJ, Smith, A, Heckelman, PE, eds, The Merck Index, Thirteenth Edition. Whitehouse Station, New Jersey, USA: Merck Research Laboratories Division of Merck & Co. Inc., 2001; 5966.
20. Rendell, MS, Glazer, NB, Zhan, YE. Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with type 2 diabetes influence of prior antidiabetic drug regimen. J Diabetes Complicat 2003; 17: 211–217.
21. Masiello, P, Broca, C, Gross, R, Roye, M, Manteghetti, M, Hillaire-Buys, D, et al. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998; 47: 224–229.
22. Yanardag, R, Ozsoy-Sacan, O, Bolkent, S, Orak, H, Karabulut-Bulan, O. Protective effects of metformin treatment on the liver injury of streptozotocin-diabetic rats. Hum Exp Toxicol 2005; 24: 129–135.
23. Soon, YY, Tan, BKH. Evaluation of the hypoglycemic and antioxidant activities of Morida officinalis in streptozotocin induced diabetes rats. Singapore Med J 2000; 43: 77–85.
24. Fraga, CG, Leibouitz, BE, Toppel, AL. Lipid peroxidation measured as TBARS in tissue slices: characterization and comparison with homogenates and microsomes. Free Radical Bio Med 1988; 4: 155–161.
25. Jiang, ZY, Hunt, JV, Wolff, SD. Ferrous sulphate oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low-density lipoprotein. Anal Biochem 1992; 202: 384–389.
26. Ellman, GC. Tissue sulfhydryl groups. Arch Biochem Biophy 1959; 82: 70–77.
27. Kakkar, P, Das, B, Viswanathan, PN. A modified spectroscopic assay of superoxide dismutase. Indian J Biochem Biophy 1984; 21: 130–132.
28. Sinha, AK. Colorimetric assay of catalase. Anal Biochem 1972; 47: 389–394.
29. Rotruck, JT, Pope, AL, Ganther, HE. Selenium: biochemical role as a component of glutathione peroxidase purification assay. Science 1973; 179: 588–590.
30. Habig, WH, Pabst, MJ, Jakpoby, WB. Glutathione transferase, a first enzymatic step in mercaturic acid formation. J Biol Chem 1974; 249: 7130–7139.
31. Omaye, ST, Turbull, TD, Sauberlich, HC. Selected method for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 1979; 62: 3–11.
32. Baker, H, Frank, 0, Angelis, B, Feingold, S. Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol. Nutr Rep Inv 1951; 21: 531–536.
33. Lowry, OH, Rosenbrough, NJ, Farr, AL, Randall, RJ. Protein measurement with Folin Phenol reagent. J Biol Chem 1951; 193: 265–278.
34. Duncan, BD. Multiple ranges tests for correlated and heteroscedastic means. Biometrics 1957; 13: 359–364.
35. Bonnefont-Rousselot, D. Glucose and reactive oxygen species. Curr Opin Nutr Metab Care 2002; 5: 561–568.
36. Ruhe, RC, Mcdonald, RB. Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J Am Coll Nutr 2001; 20: 363S–369S.
37. Bucala, R, Cerami, A. Advanced glycosylation: chemistry, biology and implications for diabetes and aging. Adv Pharmacol 1992; 23: 1–34.
38. West, IC. Radicals and oxidative stress in diabetes. Diabetic Med 2000; 17: 171–180.
39. Bayraktutan, U. Free radicals, diabetes and endothelial dysfunction. Diabetes Obes Metab 2002; 4: 224–238.
40. Sies, H. Strategies of antioxidant defence. Eur J Biochem 1993; 215: 213–219.
41. Gorey, KC, Soresso, D, Moak, SA. Comparison of superoxide dismutase activities in isolated rat and guinea pig islets of langerhans. Horm Metab Res 1993; 25: 649–650.
42. Grankvist, K, Markud, S, Toijedahl, IB. Superoxide dismutase is a prophylactic against alloxan diabetes. Nature 1981; 294: 158–160.
43. Quine, SD, Raghu, PS. Effects of (-)epicatechin, a flavonoid on lipid peroxidation and antioxidants in streptozotocin-induced diabetic liver, kidney and heart. Pharmacol Rep 2005; 57: 610–615.
44. Feillet, C, Rock, E, Coudary, C. Lipid peroxidation and antioxidants status in experimental diabetes. Clin Chim Acta 1999; 284: 31.
45. Halliwell, B, Gutteridge, JMC. Free radicals and toxicology. In: Davies Kelvin JA et al., eds, Free Radicals in Biology and Medicine. Oxford, UK: Clarendon Press, 1985, 1–27.
46. Mccord, JM, Keele, BB, Fridovich, I. An enzyme based theory of obligate naerobiosis, the physiological functions of superoxide dismutase. Proc Natl Acad Sci USA 1976; 68: 1024–1027.
47. Chance, B, Greenstein, DS, Roughton, RJW. The mechanism of catalase action-steady state analysis. Arch Biochem Biophys 1952; 37:301–339.
48. Searle, AJ, Wilson, R. Glutathione peroxide effect of superoxide, hydroxyl and bromine free radicals on enzyme activity. Int J Radiat Biol 1980; 37: 213–17.
49. Bruce, A, Freeman, D, James, C. Biology of disease-free radicals and tissue injury. Lab Invest 1982; 47: 412–426.
50. Pari, L, Saravanan, R. Role of diasulin, an herbal formulation on antioxidant status in chemical induced diabetes. Int J Pharmacol 2006; 2: 110–115.
51. Garg, MC, Bansal, DB. Protective antioxidant effect of vitamin C and vitamin E in streptozotocin induced diabetic rats. Indian J Exp Biol 2000; 38: 101–104.
52. Higuchi, Y. Lipid peroxide and alpha-tocopherol in rat with streptozotocin induced diabetes mellitus. Acta Med Okayama 1982; 36: 165–169.
53. Meister, A. New aspects of gulutathion biochemistry and transport selective alterations of glutathione metabliosm. Nutri Rev 1984; 42: 397–410.
54. Nicotera, P, Orrenius, S. Role of thiols in protection against biological reactive intermediates. Adv Exp Med Biol 1986; 197: 41–49.
55. McLennan, SV, Heffeman, S, Wright, L, Rae, C, Fisher, E, Yue, DK, Turtle, JR. Changes in hepatic glutathione metabolism in diabetes. Diabetes 1991; 40: 344–348.